Literature DB >> 9313692

Neoadjuvant therapy for oesophageal cancer.

G Mathew1, G G Jamieson.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9313692     DOI: 10.1002/bjs.1800840902

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  4 in total

1.  Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect.

Authors:  Y Hosoya; H Shibusawa; H Nagai; I Ueno; K Sakuma; T Nagashima; N Kobayashi; K Kanazawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.

Authors:  B Dunne; J V Reynolds; E Mulligan; A Kelly; M Griffin
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

3.  Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?

Authors:  Y Tabira; T Okuma; K Kondo; M Yoshioka; T Mori; M Tanaka; K Nakano; N Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-08

4.  Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.

Authors:  Andreas-Claudius Hoffmann; Daniel Vallböhmer; Klaus Prenzel; Ralf Metzger; Michaela Heitmann; Susanne Neiss; Fredericke Ling; Arnulf H Hölscher; Paul M Schneider; Jan Brabender
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-04       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.